Enveric Biosciences annual gross margin
2016
2017
2018
2019
Enveric Biosciences's gross margin was 20.42% for fiscal 2019.
View full Enveric Biosciences company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2019 | 2019-12-31 | 20.42% | −0.47 pp |
| 2018 | 2018-12-31 | 20.89% | −0.18 pp |
| 2017 | 2017-12-31 | 21.07% | +1.90 pp |
| 2016 | 2016-12-31 | 19.17% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2020 | 2020-09-30 | 22.25% | +1.49 pp |
| Q2 2020 | 2020-06-30 | 22.02% | +0.40 pp |
| Q1 2020 | 2020-03-31 | 19.59% | −0.43 pp |
| Q4 2019 | 2019-12-31 | 19.08% | +0.54 pp |
| Q3 2019 | 2019-09-30 | 20.76% | −1.42 pp |
| Q2 2019 | 2019-06-30 | 21.63% | +0.06 pp |
| Q1 2019 | 2019-03-31 | 20.03% | −1.15 pp |
| Q4 2018 | 2018-12-31 | 18.53% | +0.72 pp |
| Q3 2018 | 2018-09-30 | 22.18% | +1.72 pp |
| Q2 2018 | 2018-06-30 | 21.57% | +2.55 pp |
| Q1 2018 | 2018-03-31 | 21.18% | −5.57 pp |
| Q4 2017 | 2017-12-31 | 17.81% | −2.04 pp |
| Q3 2017 | 2017-09-30 | 20.46% | +3.59 pp |
| Q2 2017 | 2017-06-30 | 19.01% | −3.68 pp |
| Q1 2017 | 2017-03-31 | 26.75% | +8.85 pp |
| Q4 2016 | 2016-12-31 | 19.85% | −12.41 pp |
| Q3 2016 | 2016-09-30 | 16.87% | −8.13 pp |
| Q2 2016 | 2016-06-30 | 22.69% | −3.42 pp |
| Q1 2016 | 2016-03-31 | 17.90% | −9.14 pp |
| Q3 2015 | 2015-09-30 | 32.26% | — |
| Q2 2015 | 2015-06-30 | 25.00% | — |
| Q1 2015 | 2015-03-31 | 26.11% | — |
| Q2 2014 | 2014-06-30 | 27.04% | — |
Across the available reported history, Enveric Biosciences's gross margin decreased from 20.89% to 20.42%, a change of −0.47 percentage points. The latest reported quarter, Q3 2020, shows 22.25%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Enveric Biosciences filings at SEC.gov ↗